Emicizumab and Proglycem (Diazoxide Suspension)
Determining the interaction of Emicizumab and Proglycem (Diazoxide Suspension) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: n.a.
Generic Name: diazoxide
Brand name: Proglycem, Hyperstat
Synonyms: Proglycem
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-Prograf
- Emicizumab-Prograf (Tacrolimus Capsules)
- Emicizumab-Prograf (Tacrolimus Granules for Suspension)
- Emicizumab-Prograf (Tacrolimus Injection)
- Emicizumab-Prograf Intravenous
- Emicizumab-Prohance
- Proglycem (Diazoxide Suspension)-Emicizumab-kxwh
- Proglycem (Diazoxide Suspension)-Emicizumab-kxwh Subcutaneous
- Proglycem (Diazoxide Suspension)-Emla
- Proglycem (Diazoxide Suspension)-Emla Topical
- Proglycem (Diazoxide Suspension)-Emo-Cort Scalp Solution Topical application
- Proglycem (Diazoxide Suspension)-Emo-Cort Topical application